http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006072601-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_be255b2305551f65c2ea4f86ccc38d3c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5fe9c34c0249a7823825a054ab0330f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5a636d5acae75088e2bf65329dc8f30f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3f705fdcf62c63acb716fd90158458d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb0cedd23238e7331635a3af8452f80e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cbc114fe090d131bfc5e4c263e503f0d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_57cf3dbe617d89f734dd09c4f7a3225d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f74ab5be251cd9cd1f482cc1e324e7f0
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63
filingDate 2006-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_658b74f4a92fd3c39003924353081ad8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3faf34d9478128a3518da47d8f7af38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb074e4db69217d755f37a187bf07e3e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2949546dcf92e5c983b185ab358ed8a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4169da281fa8d291e08d37640570769
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_660dd6aec685a21e4689c820b9142385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14f561060ace33bea8988f6e40657d64
publicationDate 2006-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2006072601-A3
titleOfInvention THERAPEUTIC USE OF GROWTH FACTORS, NsG29 AND NsG31
abstract The present invention relates to the field of therapeutic use of proteins, genes and cells, in particular to the therapy based on secreted therapeutic proteins, NsG29 and NsG31. NsG29 and NsG31 are members of a newly identified family of growth factors with a specific cystein pattern and characterised by expression in the nevous system. The secreted growth factors have potential for the treatment of disorders of the nervous system. The invention also relates to bioactive NsG29 and NsG31 polypeptide fragments and the corresponding encoding DNA sequences.
priorityDate 2005-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004007672-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004080148-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485715
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5862

Total number of triples: 40.